DSP Nifty Healthcare ETF share price
AMFI: 152306ISIN: INF740KA1ZG1DSP Mutual FundETFs
Close ₹16.30up ₹0.20 (1.24%)
Close on 28 Oct 2026, traded as HEALTHADD. Day's range ₹15.96 to ₹16.34, 5,716 units traded.
- NAVNet asset value (NAV). What one unit of the fund is worth: everything the fund owns, less what it owes, divided by the units held by investors, worked out once a day after the market closes. Net asset value (NAV) in the glossary
- ₹16.070127 Oct 2026
- Premium to NAVPremium or discount. How far the ETF's closing price on the exchange was above or below its NAV the same day: the close divided by that day's NAV, less one. Above the NAV is a premium, below it a discount. Premium or discount in the glossary
- +0.19%27 Oct 2026
- Fund sizeAssets under management. The money the fund manages for all its investors, across every plan, at the end of the month. Assets under management in the glossary
- ₹17 CrSep 2026
- Expense ratioTotal expense ratio. What the fund charges each year as a share of the money invested, taken out of the NAV every day, so the returns shown are already after it. Total expense ratio: how it is worked out
- 0.23%23 Oct 2026
- Exit loadExit load. A charge, as a share of the amount redeemed, on units sold before a set period has passed since they were bought. Exit load in the glossary
- None
- P/EP/E. What the fund pays for each rupee of yearly profit its companies earn: the total value of its shares divided by those companies' last four quarters of profit, each in proportion to what the fund holds. The profit leaves out one-off items (exceptional items and businesses sold or demerged), so one company's one-off gain cannot pull the fund's P/E down. A loss-making company lowers the profit. Shown when at least 80% of the fund's shares are counted. P/E in the glossary
- 38.530 Sep 2026
- Risk levelRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month. Riskometer in the glossary
- Very HighAug 2026
- HoldingsHoldings. The number of different securities in the fund's latest monthly portfolio: shares, bonds, money market paper and units of other funds, not cash, overnight lending or futures. Holdings in the glossary
- 2030 Sep 2026
- LaunchedLaunch date. The day the fund first allotted units to investors, at the close of its new fund offer. Launch date in the glossary
- 1 Feb 2024
DSP Nifty Healthcare ETF returns
Over each window to 27 Oct 2026
| Over | ReturnTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back. Benchmark in the glossary | Rank in categoryRank in category. The fund's place among the funds of its category with a return over the same window, highest return first. Rank in category in the glossary | Category medianCategory median. The middle return of the funds in the category over the same window: half returned more, half less. Category median in the glossary | Middle halfMiddle half of the category. The returns of the fund a quarter of the way down the category and the fund a quarter of the way up, over the same window: half the category's funds returned between the two. Middle half of the category in the glossary |
|---|---|---|---|---|---|
| 1 week | +2.31% | +2.31% | – | – | – |
| 1 month | −4.59% | −4.56% | 4 of 5 | −4.59% | −4.6% to −4.6% |
| 3 months | −3.41% | −3.35% | 4 of 5 | −3.40% | −3.4% to −3.4% |
| 6 months | Left out | – | – | +6.89% | +6.8% to +6.9% |
| 1 year | Left out | – | – | +7.39% | +7.3% to +7.4% |
| 3 years | Needs 3 years | – | – | +20.22% | +20.1% to +20.3% |
| 5 years | Needs 5 years | – | – | +13.29% | +13.2% to +13.3% |
₹10,000 put in on 3 Jul 2026, the first price after the NAV last changed level, is ₹9,692 at the NAV of 27 Oct 2026Growth of ₹10,000. What ₹10,000 put in at the NAV of the first day would be worth at the latest NAV, after the fund's expenses and before tax and any exit load. Growth of ₹10,000 in the glossaryOver a year and longer, a return is the yearly rate. Benchmark: NIFTY Healthcare TRI, over the same days as the fund. Rank, median and middle half among the Direct plans and ETFs of funds tracking Nifty Healthcare Index, each fund's return to its latest NAV on or before 27 Oct 2026. Left out: the window crosses a day the NAV changed level without the market moving, such as a unit split.
At the month end, 30 Sep 2026
| Over | Fund | BenchmarkBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer. Benchmark return in the glossary |
|---|---|---|
| 1 year | +14.44% | +14.70% |
| Since launch | +14.49% | +14.76% |
Benchmark: NIFTY Healthcare TRI. Both as the fund house states them for the month.
Return in each calendar year
- FundCalendar year return. The change in NAV from the last NAV of one year to the last NAV of the next.
- NIFTY Healthcare TRI
- Loss
Rolling returns
Per cent a year, every window from 1 Feb 2024 to 27 Oct 2026
Lowest to highestAverage
LowestLowest rolling return. The lowest yearly return of any window of this length in the fund's history, one window starting on each day it priced. Lowest rolling return in the glossaryAverageAverage rolling return. The average of the yearly returns of every window of this length in the fund's history. Average rolling return in the glossaryHighestHighest rolling return. The highest yearly return of any window of this length in the fund's history. Highest rolling return in the glossaryEnded higherWindows that ended higher. The share of all the windows of this length in which the NAV ended above where it started. Windows that ended higher in the glossary
1 year349 windows−4.6%+8.6%+23.6%93.1%
3 yearsLaunched 1 Feb 2024, needs 4 years of history
Tracking error
Against Nifty Healthcare TRI, as on 30 Sep 2026.All funds tracking Nifty Healthcare Index
- Rank on tracking errorRank among funds on the same index. The fund's place among the funds tracking the same index on the same plan: from the lowest tracking error and expense ratio, and from the highest tracking difference after fee. Rank among funds on the same index in the glossary
- 1Of 4 funds
- Rank on expense ratio
- 3Of 4 funds
- Difference after feeTracking difference after fee. The one-year tracking difference with the year's average expense ratio added back: how far the fund was from its index for reasons other than its fee. Tracking difference after fee in the glossary
- −0.03 ptsRank 1 of 4 funds
Against its index, by window
| Measure | This fund |
|---|---|
| Tracking errorTracking error. How much an index fund's daily returns differed from its index's, stated as a yearly figure. Tracking error in the glossary | 0.02% |
| Difference, 1 yearTracking difference. The index fund's return less its index's return over the same period; the fund's costs make it negative. Tracking difference in the glossary | −0.27 pts |
| Difference since launch | −0.27 pts |
Difference: the fund's return less the index's, in percentage points.
ETFs tracking Nifty Healthcare Index
 Axis Nifty Healthcare ETF | 0.02% | −0.43 pts | −0.03 pts | 0.44% | 24 |
 ICICI Prudential Nifty Healthcare ETF | 0.02% | −0.19 pts | −0.04 pts | 0.16% | 231 |
 Aditya Birla Sun Life Nifty Healthcare ETF | 0.02% | −0.23 pts | −0.04 pts | 0.20% | 75 |
| DSP Nifty Healthcare ETF | 0.02% | −0.27 pts | −0.03 pts | 0.21% | 17 |
4 funds in Sep 2026. Expense ratio at the month end; after fee adds back the year's average expense ratio.
Premium or discount to NAV, each session, HEALTHADD
- Premium
Highest +7.16%, 13 Oct 2026.Lowest −0.89%, 16 Sep 2026.
- Median premium
- 0.05%21 sessions in Sep 2026
- Lowest
- −0.89%21 sessions in Sep 2026
- Highest
- 0.87%21 sessions in Sep 2026
DSP Nifty Healthcare ETF expense ratio and exit load
Per cent of the money invested, a year. Each month shows its last day filed; the parts were redefined from Apr 2026.
- 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies. Expense ratio, 30-day average in the glossary
- 0.23%Over the last 20 days filed
Total expense ratio, month by month
Expense ratio highest 0.31%, Aug 2026.Expense ratio lowest 0.19%, Feb 2025.
What the expense ratio is made of
| Part | A year |
|---|---|
| Base expense ratioBase expense ratio. The part of the expense ratio that pays the fund house and the distributor, before brokerage, transaction costs, levies and GST. Base expense ratio in the glossary | 0.17% |
| Brokerage | None |
| Transaction costs | None |
| Statutory levies | 0.06% |
Per cent of assets a year, filed for 23 Oct 2026. The parts add up to that day's total.
DSP Nifty Healthcare ETF AUM
₹ crore, every plan of the fund together.
- Average assetsAverage assets under management. The money the fund managed, averaged over every day of the quarter, added up across its plans.
- ₹18 CrQuarter to Sep 2026
Average assets by quarter
The latest quarter is the largest since the quarter to Mar 2024.
Assets at each month end
Highest ₹18 Cr, Jul 2026.Lowest ₹9 Cr, Feb 2025.
DSP Nifty Healthcare ETF portfolio
Portfolio disclosed for 30 Sep 2026.
Holdings on 30 Sep 2026
| Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month. Large, mid and small cap in the glossary | Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. Weight in the fund in the glossary | Held since. The first month end of the fund's current run of holding this position; marked "or earlier" where that month is the fund's first portfolio on record or the first after a gap in its portfolios. Held since in the glossary | |||
|---|---|---|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | Large cap13th | 16.99% | 2.90 | 15,953 | Feb 2024or earlier |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | Large cap50th | 10.43% | 1.78 | 1,915 | Feb 2024or earlier |
| Apollo Hospitals EnterpriseHealthcare Services | Large cap97th | 7.42% | 1.27 | 1,551 | Feb 2024or earlier |
| Laurus LabsPharmaceuticals & Biotechnology | Mid cap171st | 6.81% | 1.16 | 5,868 | Feb 2024or earlier |
| CiplaPharmaceuticals & Biotechnology | Large cap99th | 6.69% | 1.14 | 8,479 | Feb 2024or earlier |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | Mid cap104th | 6.64% | 1.13 | 9,189 | Feb 2024or earlier |
| Torrent PharmaceuticalsPharmaceuticals & Biotechnology | Large cap61st | 6.24% | 1.06 | 2,217 | Feb 2024or earlier |
| Max Healthcare InstituteHealthcare Services | Mid cap111th | 6.11% | 1.04 | 11,213 | Feb 2024or earlier |
| LupinPharmaceuticals & Biotechnology | Mid cap105th | 4.36% | 0.74 | 3,660 | Feb 2024or earlier |
| Aurobindo PharmaPharmaceuticals & Biotechnology | Mid cap138th | 4.08% | 0.70 | 4,164 | Feb 2024or earlier |
| Fortis HealthcareHealthcare Services | Mid cap156th | 3.54% | 0.60 | 7,851 | Mar 2025 |
| Glenmark PharmaceuticalsPharmaceuticals & Biotechnology | Mid cap176th | 3.11% | 0.53 | 2,269 | Feb 2024or earlier |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | Mid cap164th | 2.75% | 0.47 | 909 | Feb 2024or earlier |
| Zydus LifesciencesPharmaceuticals & Biotechnology | Mid cap114th | 2.54% | 0.43 | 3,734 | Feb 2024or earlier |
| Mankind PharmaPharmaceuticals & Biotechnology | Mid cap119th | 2.51% | 0.43 | 1,707 | Mar 2025 |
Weight is per cent of the fund's net assets; value in ₹ crore.
Cash and receivables on 30 Sep 2026
| TREPS / Reverse Repo Investments | 0.10% | 0.02 |
| Net Receivables/Payables | −0.02% | −0.01 |
Weight is per cent of the fund's net assets; value in ₹ crore.
- Largest holdingLargest holding. The share of the fund in its single largest position, cash and futures not counted as positions. Largest holding in the glossary
- 16.99%Sun Pharmaceutical Industries
- Top 5 holdingsTop 5 holdings. The share of the fund held in its five largest positions. Top 5 holdings in the glossary
- 48.34%
- Top 10 holdingsTop 10 holdings. The share of the fund held in its ten largest positions. Top 10 holdings in the glossary
- 75.77%
- Effective holdingsEffective number of holdings. The number of equal-sized positions that would be as concentrated as the fund's actual weights. Effective number of holdings in the glossary
- 13.1Taken over 99.92% of the fund
Asset allocation
Asset allocation. What the fund owns, by kind of asset, each as a share of its net assets; futures and options are shown beside it, not in it, since they are contracts rather than assets bought. Asset allocation in the glossary- Indian shares99.92%
- Cash and receivables0.08%
Per cent of the fund's net assets.
Large, mid and small cap
- Large cap47.81%
- Mid cap48.39%
- Small cap3.80%
Per cent of the fund's Indian shares. By the list for the six months to Jun 2026.
Sector allocation
Sector weight. The fund's shares grouped by the business each company is in, less the futures sold on them, each group as a share of the fund's net assets. Sector weight in the glossary1sector
- Healthcare99.92%
Per cent of the fund's net assets, less the futures sold on its shares, Sep 2026.
Sector allocation month by month
| 13 months | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare20 companies | 99.92% | 99.94% | 99.78% | 99.87% | 99.93% | 99.95% | 99.91% | 99.88% | 99.96% | 99.91% | 99.93% | 99.97% |
Per cent of the fund's net assets, less the futures sold on its shares, at each month end, Oct 2025 to Sep 2026; the line runs from Sep 2025.
Bought and sold
Sep 2026 against Aug 2026, position by position.
Positions changed, month by month
- New
- Added
- Trimmed
- Sold out
- New positionsNew positions. Holdings in this month's portfolio that were not in the month before. New positions in the glossary
- 23.80% of the fund
- Sold outSold out. Holdings in last month's portfolio that are gone from this one, other than a bond or deposit repaid on its due date. Sold out in the glossary
- 21.80% of the fund before
- Added toAdded to. Holdings with more units than the month before. Where the fund states no units, a weight that rose by more than a tenth. Added to in the glossary
- 0
- TrimmedTrimmed. Holdings with fewer units than the month before. Where the fund states no units, a weight that fell by more than a tenth. Trimmed in the glossary
- 18
- UnchangedUnchanged. Holdings with the same number of units as the month before. Their weight can still move with the price. Unchanged in the glossary
- 0
- Traded at leastTraded at least. The smaller of the weight bought in new positions and the weight sold out of old ones, cash left out: the least the fund must have bought and sold in the month. Traded at least in the glossary
- 1.80%
- Weight that movedWeight that moved. Half the sum of every position's change in weight between the two month ends, new and sold positions included; price moves alone raise it. Weight that moved in the glossary
- 5.26%
Changes in Sep 2026
| What changed. New: not held the month before. Added or trimmed: more or fewer units than the month before, or, where no units are stated, a weight that moved by more than a tenth. Sold out: held the month before, gone now. Matured: a bond or deposit whose repayment date fell between the two portfolios, so it was repaid rather than sold (one sold in its last days reads the same). What changed in the glossary | Change in weight. The holding's weight this month less its weight the month before, in percentage points; a price move alone changes it. Change in weight in the glossary | ||||
|---|---|---|---|---|---|
| Gland Pharma | New | 2.04% | 0.00% | +2.04 pts | +1,201 |
| Krishna Institute of Medical Sciences | New | 1.76% | 0.00% | +1.76 pts | +4,021 |
| Piramal Pharma | Sold out | – | 1.15% | −1.15 pts | −9,689 |
| Sun Pharmaceutical Industries | Trimmed | 16.99% | 18.07% | −1.08 pts | −543 |
| Syngene International | Sold out | – | 0.65% | −0.65 pts | −2,960 |
| Dr. Reddy's Laboratories | Trimmed | 6.64% | 6.05% | +0.59 pts | −306 |
| Max Healthcare Institute | Trimmed | 6.11% | 6.67% | −0.56 pts | −380 |
| Fortis Healthcare | Trimmed | 3.54% | 4.06% | −0.52 pts | −266 |
| Apollo Hospitals Enterprise | Trimmed | 7.42% | 7.87% | −0.45 pts | −52 |
| Laurus Labs | Trimmed | 6.81% | 6.41% | +0.40 pts | −193 |
| Biocon | Trimmed | 2.28% | 2.53% | −0.25 pts | −612 |
| Lupin | Trimmed | 4.36% | 4.57% | −0.21 pts | −123 |
| Mankind Pharma | Trimmed | 2.51% | 2.35% | +0.16 pts | −56 |
| Torrent Pharmaceuticals | Trimmed | 6.24% | 6.39% | −0.15 pts | −68 |
| Cipla | Trimmed | 6.69% | 6.82% | −0.13 pts | −287 |
Weights are per cent of the fund's net assets; a change in weight is in percentage points.
Holdings month by month
| Holding | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical Industries | 18.14%Added | 19.21%Cut | 18.53%Added | 18.04%Added | 18.35%Added | 19.44%Added | 19.05%Added | 18.36%Added | 18.12%Added | 18.29%Cut | 18.07%Cut | 16.99%Cut |
 Divi's Laboratories | 8.71% | 8.19%Cut | 8.26%Cut | 8.21%Added | 8.10%Added | 7.89%Added | 8.22%Added | 8.17%Added | 7.68%Added | 8.88%Cut | 10.34%Cut | 10.43%Cut |
 Apollo Hospitals Enterprise | 7.90%Added | 7.37%Cut | 7.37%Added | 7.65%Added | 8.01%Added | 7.97%Added | 7.82%Added | 8.11%Added | 8.21%Added | 8.00%Cut | 7.87%Cut | 7.42%Cut |
 Laurus Labs | 3.77%Added | 3.99%Cut | 4.38%Cut | 4.00%Added | 4.17%Added | 4.03%Added | 4.26%Added | 5.11%Added | 5.42%Added | 6.13%Cut | 6.41%Cut | 6.81%Cut |
 Cipla | 8.60%Added | 8.57%Cut | 8.65%Cut | 7.96%Added | 7.56%Added | 7.20%Added | 7.33%Added | 7.60%Added | 7.58%Added | 7.19%Cut | 6.82%Cut | 6.69%Cut |
 Dr. Reddy's Laboratories | 7.43%Added | 7.63%Cut | 7.88%Cut | 7.93%Added | 7.82%Added | 7.99%Added | 8.02%Added | 7.66%Added | 7.60%Added | 6.07%Cut | 6.05%Cut | 6.64%Cut |
 Torrent Pharmaceuticals | 3.79%Added | 3.87%Cut | 4.10%Cut | 4.43%Added | 4.50%Added | 4.61%Added | 4.36%Added | 4.45%Added | 4.45%Added | 6.52%Added | 6.39%Cut | 6.24%Cut |
 Max Healthcare Institute | 8.69%Added | 8.60%Cut | 7.91%Cut | 7.60%Added | 8.10%Added | 7.48%Added | 7.35%Added | 6.92%Added | 7.72%Added | 7.10%Cut | 6.67%Cut | 6.11%Cut |
 Lupin | 4.84%Added | 5.01%Cut | 5.20%Cut | 5.57%Added | 5.57%Added | 5.86%Added | 5.56%Added | 5.30%Added | 5.40%Added | 5.09%Cut | 4.57%Cut | 4.36%Cut |
 Aurobindo Pharma | 3.24%Added | 3.42%Cut | 3.37%Cut | 3.61%Added | 3.41%Added | 3.81%Added | 3.87%Added | 3.84%Added | 4.01%Added | 3.80%Cut | 4.09%Cut | 4.08%Cut |
 Fortis Healthcare | 5.43%Added | 4.77%Cut | 4.69%Cut | 4.74%Added | 4.90%Added | 4.33%Added | 4.79%Added | 4.66%Added | 4.58%Added | 4.27%Cut | 4.06%Cut | 3.54%Cut |
 Glenmark Pharmaceuticals | 2.90% | 2.92%Cut | 3.12%Cut | 3.24%Added | 3.22%Added | 3.35%Added | 3.61%Added | 3.30%Added | 3.05%Added | 2.92%Cut | 3.21%Cut | 3.11%Cut |
 Alkem Laboratories | 3.16%Added | 3.18%Cut | 3.28%Added | 3.55%Added | 3.28%Added | 3.24%Added | 3.15%Added | 3.10%Added | 2.99%Added | 2.92%Cut | 2.68%Cut | 2.75%Cut |
 Zydus Lifesciences | 2.48%Added | 2.34%Cut | 2.33%Cut | 2.37%Added | 2.30%Added | 2.28%Added | 2.22%Added | 2.60%Added | 2.56%Added | 2.45%Cut | 2.50%Cut | 2.54%Cut |
 Mankind Pharma | 2.74% | 2.53%Cut | 2.53%Cut | 2.57%Added | 2.54%Added | 2.37%Added | 2.53%Added | 2.59%Added | 2.65%Added | 2.43%Cut | 2.35%Cut | 2.51%Cut |
Per cent of the fund's net assets at each month end, Oct 2025 to Sep 2026. Under it, the change on the fund's previous month. "After a gap" is a holding after a month with no portfolio on record, so when it was bought is not known; "Not filed" is one gone across such a gap.
DSP Nifty Healthcare ETF fund managers
Managers now
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. Return in the manager's time in the glossary | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. Benchmark over the same days in the glossary | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. Difference from the benchmark in the glossary | Portfolio changed after the handover. How much of the portfolio was different three months after the manager took over: half the sum of every holding's change in weight, with each side's holdings scaled to add up to 100 so a move into cash does not count. Portfolio changed after the handover in the glossary | Portfolio changed before the handover. The same measure over the three months before the manager took over, since portfolios change anyway. Portfolio changed before the handover in the glossary | Assets the manager runs. The latest monthly size of every fund the manager runs now, added up; a fund run with others counts in full for each of its managers, and the line under it counts only the funds they run alone. Assets the manager runs in the glossary | ||
|---|---|---|---|---|---|---|---|---|
| Anil GhelaniPrimary | Feb 2024 | – | – | – | – | – | 41 | ₹17,327 Cr |
| Diipesh ShahComanage | Feb 2024 | – | – | – | – | – | 41 | ₹17,327 Cr |
| Neha RathiComanage | May 2026 | – | – | – | 5.3% | 2.2% | 41 | ₹17,327 Cr |
Returns are the regular plan's growth NAV, from the day each took over to the latest NAV, beside the benchmark over the same days.
Other funds they run
| Fund | |||||
|---|---|---|---|---|---|
| DSP Nifty 50 Equal Weight Index FundAnil Ghelani | Jul 2019 | +13.96%a year | +15.39% | −1.44 pts | ₹2,550 Cr |
| DSP BSE Liquid Rate ETFAnil Ghelani | Mar 2024 | +5.55%a year | – | – | ₹1,889 Cr |
| DSP Nifty PSU Bank ETFAnil Ghelani | Jul 2023 | +19.49%a year | +19.82% | −0.33 pts | ₹1,434 Cr |
| DSP Nifty 50 Equal Weight Index FundDiipesh Shah | Nov 2020 | +17.49%a year | +18.65% | −1.16 pts | ₹2,550 Cr |
| DSP BSE Liquid Rate ETFDiipesh Shah | Mar 2024 | +5.55%a year | – | – | ₹1,889 Cr |
| DSP Nifty PSU Bank ETFDiipesh Shah | Jul 2023 | +19.49%a year | +19.82% | −0.33 pts | ₹1,434 Cr |
| DSP Nifty Next 50 Index FundDiipesh Shah | Nov 2020 | +16.09%a year | +16.91% | −0.82 pts | ₹1,350 Cr |
| DSP Nifty 50 Equal Weight Index FundNeha Rathi | May 2026 | −5.39%over 175 days | −5.06% | −0.33 pts | ₹2,550 Cr |
| DSP BSE Liquid Rate ETFNeha Rathi | May 2026 | +2.35%over 176 days | +2.55% | −0.19 pts | ₹1,889 Cr |
| DSP Nifty PSU Bank ETFNeha Rathi | May 2026 | −3.70%over 175 days | −3.64% | −0.06 pts | ₹1,434 Cr |
The ten largest by assets, by manager. Returns are the regular plan's.
Portfolio overlap
Funds holding the most of the same securities, by weight.
Closest funds in the category
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. Portfolio overlap in the glossary | Shared holdings. The number of securities both funds hold, cash and futures left out. Shared holdings in the glossary | |
|---|---|---|
| ICICI Prudential Nifty Healthcare ETFICICI Prudential Mutual Fund | 99.90% | 20 |
| Nippon India Nifty Pharma ETFNippon India Mutual Fund | 81.09% | 16 |
| Motilal Oswal BSE Healthcare ETFMotilal Oswal Mutual Fund | 70.20% | 20 |
| HDFC Nifty Growth Sectors 15 ETFHDFC Mutual Fund | 20.26% | 4 |
| Nippon India Nifty India Manufacturing ETFNippon India Mutual Fund | 18.25% | 10 |
| Motilal Oswal Nifty India Manufacturing ETFMotilal Oswal Mutual Fund | 18.22% | 10 |
| ICICI Prudential Nifty Alpha Low- Volatility 30 ETFICICI Prudential Mutual Fund | 18.05% | 5 |
| HDFC Nifty100 Low Volatility 30 ETFHDFC Mutual Fund | 17.60% | 5 |
| Kotak Nifty 100 Low Volatility 30 ETFKotak Mahindra Mutual Fund | 17.60% | 5 |
| ICICI Prudential Nifty 100 Low Volatility 30 ETFICICI Prudential Mutual Fund | 17.59% | 5 |
Portfolios for Sep 2026. Overlap is per cent of the portfolio the two funds hold in common.
Changes to the fund
Newest first.
2026
- 1 AprExpenseExpense ratio stated under the new rules: a base ratio, with brokerage, levies and GST on top
Risk level by month
| Months | Fund | BenchmarkBenchmark's risk level. The riskometer level of the fund's benchmark index for the same month, on the same six-step scale as the fund's own. Benchmark's risk level in the glossary |
|---|---|---|
| Mar 2025 to Aug 202618 months | Very High | Very HighNIFTY Healthcare TRI |
The riskometer at each month end, the fund's and its benchmark's. A month with none on record is left out.
Fund details
Objective
The Scheme seeks to provide returns that, before expenses, correspond to the total return of the underlying index (Nifty Healthcare TRI), subject to tracking errors. There is no assurance that the investment objective of the Scheme will be achieved.
Asset allocation
- A. Equity and Equity Related Securities of companies constituting Nifty Healthcare Index, the Underlying Index : 95% - 100%. B. Cash and Cash Equivalents : 0% - 5%
- For detailed asset allocation pattern, please refer to the Scheme Information Document
Type of scheme
An open ended scheme replicating/ tracking Nifty Healthcare Index
- Stated category
- Exchange Traded Fund (ETF)
- Benchmark
- Nifty Healthcare TRI
- Risk level at launch
- Very High
- New fund offer
- 11 Jan 2024 to 25 Jan 2024
- Units first allotted
- 1 Feb 2024
- Open for sale again
- 7 Feb 2024
- Price at the offer
- ₹1 a unit
- Minimum at the offer
- ₹5,000
Plans and codes
| Plan | AMFI code | ISIN | First NAV |
|---|---|---|---|
| Regular Growth | 152306 | INF740KA1ZG1 | 1 Feb 2024 |
This fund
- Scheme information documentThe fund's objective, terms, costs and risks in full
Factsheet
- Factsheet September 2026DSP Mutual Fund, Sep 2026
Statement of additional information
- SAI DSP Mutual FundDSP Mutual Fund, Oct 2026
Annual report
- Annual Report for the Financial Year 2025 – 2026 (For all DSP Schemes)DSP Mutual Fund, Mar 2026
- Abridged Annual Reports For Financial Year 2025-26 (For our Fixed Maturity Plans (Live and Matured))DSP Mutual Fund, Mar 2026
- Abridged Annual Reports For Financial Year 2025-26 (For our Equity Schemes)DSP Mutual Fund, Mar 2026
- Abridged Annual Reports For Financial Year 2025-26 (For our Hybrid Schemes and Multi Asset Scheme)DSP Mutual Fund, Mar 2026
Riskometer disclosure
- Changes in risk level of schemes and other details during FY 2025- 2026DSP Mutual Fund, Mar 2026
Portfolio overlap disclosure
- Portfolio overlap 30 sepDSP Mutual Fund, Sep 2026